Overview
In order to ensure long-term profitability of life science businesses in Japan, development of innovative drugs and devices for diseases with significant unmet needs will be key. It will be important for MNCs and domestic companies to consider alliances, in-licensing and/or M&A activities to enhance their pipeline to bring new and innovative drugs and devices to the market. In this context, Finglobedirect, which has been providing company and financial information globally since two decades, offers Japan Life Sciences: Business Monthly report for companies in Japanese life sciences industry.
Objective
The objective of this monthly is to offer each month a database of useful information that plays a crucial role in the ongoing trade and investments in the Japanese life science sector. The monthly is specifically designed to combine the Japanese life science business news and stock price changes every month and thereby help the investors globally to assess the investment trends and opportunities in the Japanese life science sector.
Research Methodology
Our research team continuously updates news from established news portals, regional and international primary news sources, business media sites, company websites and stock exchanges. At the end of the month, our research experts identify those news stories that have played a crucial role in Japanese life science investments in the month and provide an overall report on the same.
Further, our team also compiles stock prices for the listed Japanese life science companies from Japanese stock exchanges daily. And at the end of each month, our research experts analyze and summarize the stock prices to give a complete picture of monthly stock market performance of the Japanese life science companies.
- Comprehensive focus on listed and non-listed Japanese life science companies as well as foreign MNC units in Japan
- Covers all the important business transactions of the month
- Provides list of companies covered every month in news
- Company news presented by company name
- Company news also provided by industry and by news category
- Presents monthly stock price analysis covering top gainers and decliners
- Provides latest quarter’s financial performance for Japanese life science companies
- Ticker mentioned for all listed companies included in the monthly
Section 2: Company News - By Industry
Section 3: Company News - By News Category
Section 4: Stock Analysis - Top Gainers and Decliners in Japan Life Science Sector
Section 5: Financial Performance of Japan Life Science Sector
- Most-recent news coverage and stock price analysis provided by Finglobedirect’s 24/7 researchers at 3 global offices
- Original news source links provided for all news for further reference
- Analysts with years of experience analyze the investment trends and stock market performance each month for Japanese life science industry
- Most of the available news resources comprehensively covered (including established news portals, reliable primary and secondary news sources, business media sites, company websites, press releases, and stock exchanges)
- Stock market information compiled comprehensively from Japanese stock exchanges
Format |
Properties |
|
|
Electronic (PDF) |
The report will be emailed to you in PDF format. |
This is a single user license, allowing one specific user access to the product. |
Subscription Fees:
- $450 Annual for 12 Issues
- $750 for annual subscriptions of three Japan Life Sciences Business News Publications (savings of $250)
- Japan Life Sciences: Business Daily $ 300 Annual for 300 Dailies ($1/day!)
- Japan Life Sciences: Business News Sunday Report $250 Annual for 50 Weekly Sunday Reports
- Japan Life Sciences: Business Monthly $450 Annual for 12 Issues
Please send us an email for any further queries to info@finglobedirect.com